Ph.D. graduate Anna Blakney and senior fellow Mary Wallingford were selected to participate in Rising Stars in Biomedical, held at MIT November 9-10, 2016.
BioE's Professor Emeritus Allan Hoffman, and adjunct faculty David Baker and Miqin Zhang are among 29 UW researchers to be included on 2016's "Highly Cited Researchers" report by Clarivate Analytics.
AVS (American Vacuum Society) is an international community of scientists, engineers and instrument manufacturers which strives to promote research and communicate knowledge in the important areas of surface, interface, vacuum and thin film science/technology for the advancement of humankind.
UW Bioengineering Research Associate Professor Dr. Eric Chudler recently returned from a trip to Sherbaling [...]
Photo: Northwest Kidney Institute Release originally appeared on UW Health Sciences NewsBeat on November 14, [...]
We are pleased to announce a call for applications to the Bioengineering Cardiovascular Training Grant [...]
Nuttada is developing OLA-SIMPLE, which aims to be the first instrument-free device that emulates the diagnostic capabilities of laboratory testing to provide a rapid visual readout of HIV diagnosis, viral load and drug resistance at the point of care.
College of Engineering features Bioengineers without Borders team’s project to create portable anesthesia device for developing countries
Photo: Eric Swanson and David Peeler, Bioengineers Without Borders team members and Bioengineering graduate students. A [...]
Washington Molecular Imaging and Therapy (WAMIT) Center receives College of Engineering Strategic Research Initiatives Award
WAMIT will establish a one-of-a-kind molecular imaging center at UW to make major advances in precision medicine leading the next major wave in medical diagnosis and treatment, and significantly strengthen the infrastructure for translating scientific discoveries into clinical applications.
The researchers were selected for their proposal and business plan to develop a targeted drug delivery system for breast cancer which targets a specific population of tumor-promoting cells.